Decreasing bioavailable copper in vivo modulates tumor vessel dimensions. by Andrew Crowe (450839)

Decreased TPP1 activity in various <i>Cln2</i>^{<i>R207X/R207X</i>} mouse tissues. by Ryan D. Geraets (3993353)

Deletion of both Nesprin 1 and 2 causes decreased cardiac wall thickness and impaired cardiac function. by Indroneal Banerjee (525222)

2-MeSADP treatment decreases <i>in vivo</i> lesions induced by single vessel photothrombosis. by Wei Zheng (25452)

CXCL12 expression results in decreased proliferation of PDAC cells. by Ishan Roy (530438)

“…(C–D) Propidium Iodide cell cycle analysis revealed a decrease in percentage of cells in the G₂ phase in CXCL12-expressing cells compared to GFP controls. (*), (**), and (***) denote <i>P</i>≤0.05, <i>P</i>≤0.01, and <i>P</i>≤0.001 respectively in comparison to control cells (GFP). …”

Buffers render spiking more irregular by decreasing spatial coupling. by Alexander Skupin (244450)

“…Squares correspond to 0.12 pA and dots to 1.2 pA. <b>E</b>: Corresponding − dependence of simulations in panel D. …”

S274 phosphorylation in jejunum is decreased mostly at the middle part of the villus. by Lalita Oparija-Rogenmozere (8911535)

R1R2 decreases inflammatory cell accumulation and VCAM-1 and ICAM-1 levels. by Ting-Hein Lee (225627)

Treatment with anti-JAM-C antibody decreases the T-cell response by Gaby Palmer (636)

Increased apoptosis and decreased invasion in MCPH1 overexpressing cells. by Thejaswini Venkatesh (385655)

Knockdown of MRN complex decreases HBV cccDNA level. by Kaitao Zhao (3617825)

Overexpression of Myc increases mutation frequency and decreases lifespan at 29 by Christina Greer (359442)

OPN-deficiency decreases HFD-induced liver inflammation and fibrosis. by Andoni Lancha (335824)

Upregulation of astroglial Cx30 decreased LTP and recognition memory. by Eléonore Hardy (15208385)

“…<p><b>(a)</b> Tetanus-induced LTP curves (arrow, two 100 Hz tetani for 1 s, interval 20 s) and representative traces. …”

T2R neutrophils show spontaneous <i>ex vivo</i> NETs production, which decreases with thalidomide treatment. by Camila Oliveira da Silva (7365539)

Decreased expression of transferrin receptor (TfR) but not transferrin (Tf) in R6/2 HD mice. by Jianfang Chen (469733)

“…Quantification of neuronal cell body TfR immunoreactivity in cortex and striatum of wild-type and R6/2 mice. <b>C</b>-<b>D</b>. Western blot analysis of TfR detects a band migrating at ~95 kDa consistent with TfR (<b>C</b>); this band is significantly decreased in HD as compared to wild-type mice in cortex and striatum (<b>D</b>). …”

Increased ROS level decreases RLS in respiratory-deficient cells. by Dae-Gwan Yi (5410298)

EC-SOD is decreased in the pulmonary artery in response to chronic hypoxia. by Tanya Hartney (15297)

SPL decreases diabetes-induced oxidative stress in GL and PT. by Eduardo Molina-Jijón (4020464)

“…SPL treatment prevents diabetes-induced increment in O₂^●― production (A) by using nicotinamide adenine dinucleotide phosphate (NADPH) as substrate and, diphenyleneiodonium (DPI) as inhibitor, lipid peroxidation (B) and protein carbonylation (C) and decreased GSH content (D) in GL (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s003" target="_blank">S3 Fig</a>). …”

Cilostazol decreases OC formation and bone resorption induced by RANKL. by Ke Ke (583325)